Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Transpl Infect Dis ; 22(5): e13384, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-610833

ABSTRACT

COVID-19 is now a pandemic with increasing numbers of cases and deaths. In addition to the economic and social damage caused by COVID-19 outbreak prolongation, damage caused by delayed treatment of other diseases such as severe cirrhosis is also serious. We aimed to describe the effect of COVID-19 on the number of liver transplants (LT) in South Korea. The number of LT performed in Korea during the Middle East Respiratory Syndrome (MERS) outbreak, and the COVID-19 pandemic was compared with the average number of LT performed in the past 5 years. There were 108.5 cases of LT performed per month during the MERS outbreak. It was 11% lower than the average of 122.8 cases per month for the last 5 years. LDLT and DDLT decreased by 13% to 75.3 cases and by 7.5% to 33.2 cases per month during the MERS epidemic, respectively. From January to March 2020 (COVID-19 outbreak), the number of LT did not decrease significantly. The lockdown caused by COVID-19 did not affect the number of liver transplants in Korea. Establishing a safe process and procedure of liver transplantation within safe boundaries can be beneficial in reducing the side effects of lockdown and saving patients' lives.


Subject(s)
COVID-19/prevention & control , Communicable Disease Control/standards , Coronavirus Infections/prevention & control , End Stage Liver Disease/surgery , Liver Transplantation/statistics & numerical data , COVID-19/epidemiology , COVID-19/transmission , COVID-19/virology , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , End Stage Liver Disease/mortality , Humans , Liver Transplantation/methods , Liver Transplantation/standards , Living Donors/statistics & numerical data , Middle East Respiratory Syndrome Coronavirus/pathogenicity , Pandemics/prevention & control , Republic of Korea/epidemiology , SARS-CoV-2/pathogenicity , Waiting Lists/mortality
SELECTION OF CITATIONS
SEARCH DETAIL